Insulin Resistance Predicts Atherogenic Lipoprotein Profile in Nondiabetic Subjects
Table 1
Demographic, clinical profile, and anthropometry of the subjects according to the presence of insulin resistance.
Variables
Total ()
Non-IR group ()
IR group ()
Women (n, %)
110.0 (60.8)
40.0 (62.5)
70.0 (59.8)
0.725
Age, years (mean, SD)
52.1 (10.3)
51.3 (12.0)
52.5 (9.3)
0.476
Weight, kg (mean, SD)
80.1 (16.9)
67.4 (10.6)
87.0 (15.7)
<0.001
BMI, % (mean, SD)
30.1 (5.5)
25.0 (2.6)
32.9 (4.6)
<0.001
WC, cm (mean, SD)
98.3 (13.0)
86.1 (7.4)
105.0 (10.2)
<0.001
FM, % (mean, SD)
35.2 (11.9)
29.5 (9.8)
38.3 (11.9)
<0.001
SBP, mmHg (mean, SD)
134.3 (19.5)
130.2 (21.5)
136.6 (18.0)
0.004
DBP, mmHg (mean, SD)
82.0 (10.2)
78.5 (10.2)
83.9 (9.7)
<0.001
Smoking (n, %)
34.0 (18.8)
16.0 (25.0)
18.0 (15.4)
0.113
Statin (n, %)
45.0 (24.9)
15.0 (23.4)
30.0 (25.6)
0.743
Fibrate (n, %)
4.0 (2.2)
1.0 (1.6)
3.0 (2.6)
0.661
Data presented as mean (standard deviation) or absolute value (frequency). Comparative analysis for categorical variables was performed by Pearson’s chi-square test (), and continuous variables were performed by Student’s t-test (). BMI: body mass index; WC: waist circumference; SBP: systolic blood pressure; DBP: diastolic blood pressure; non-IR group: individuals without insulin resistance; IR group: individuals with insulin resistance.
